- Verzenio 150mg 14 tablets in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive,
VERZENIO is a kinase inhibitor indicated: In combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
How fast does Verzenio work?
Although Verzenio starts inhibiting CDK4/6 enzymes quickly, it may take up two to four months before any change in outcomes, such as progression-free survival are noted. These changes have been shown to persist and deepen for the next 4 years at least.
Reviews
There are no reviews yet.